Active pharmaceutical ingredients for oncology treatments, encompassing alkylating agents, antimetabolites, and kinase inhibitors. Procured by generic drug producers and biotech firms for synthesizing injectables, orals, and infusions supplied to oncology centers, hospitals, and specialized distributors in the global pharmaceutical supply